Forskning ved Københavns Universitet - Københavns Universitet

Forside

Adjuverende medicinsk behandling tilpatienter med lokoregionalt recidiv af brystkræft

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Farah Choudary Farooq
  • Claus Kamby

There is 10-30% risk of developing isolated locoregional recurrence (ILRR) after mastectomy for primary breast cancer. Currently, there is no standard treatment for ILRR and therefore patients with ILRR cause an oncological task. This review investigates existing literature concerning relevant randomized trials of adjuvant medical treatment with chemotherapy, anti-hormonal and anti HER2 treatments for patients radically treated for ILRR. Certain groups of patients may benefit from adjuvant systemic treatment. However larger randomized trials are needed.

OriginalsprogDansk
ArtikelnummerV08150648
TidsskriftUgeskrift for Laeger
Vol/bind178
Udgave nummer5
Antal sider4
ISSN0041-5782
StatusUdgivet - feb. 2016

ID: 180941317